FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2310361040> ?p ?o ?g. }

• W2310361040 endingPage "1753" @default.
• W2310361040 startingPage "1753" @default.
• W2310361040 abstract "Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation Daisuke Morichika,1 Toshio Kubo,2 Hiroko Gotoda,1 Tomoki Tamura,1 Kadoaki Ohashi,1 Katsuyuki Hotta,1 Masahiro Tabata,2 Kazuhiko Kurozumi,3 Mitsune Tanimoto,4 Katsuyuki Kiura1 1Department of Respiratory Medicine, 2Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan; 3Department of Neurological Surgery, 4Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan Abstract: For lung cancer patients with epidermal growth factor receptor (EGFR) mutations, the advent of EGFR tyrosine kinase inhibitors (TKIs) has prolonged survival rates. Even though disease sites have been well controlled by EGFR-TKIs, some patients develop carcinomatous meningitis, which reduces their quality of life drastically. Although multidisciplinary approaches have improved patient survival and quality of life, the outcomes are not yet satisfactory. We report the case of a 54-year-old Japanese woman diagnosed with leptomeningeal metastases (LM) from a lung adenocarcinoma harboring an EGFR exon 21 L858R point mutation. She was treated with gefitinib for 2 months, and symptoms of LM emerged during the treatment period. Although the treatment was switched to erlotinib, disturbance of consciousness worsened because of progressive hydrocephalus. Because all extracranial lesions remained responsive to treatment, and the exon 20 T790M point mutation was not detected in cerebrospinal fluid, we placed a ventriculoperitoneal shunt. The patient’s disturbed consciousness improved dramatically after the shunt was placed; however, the optic and auditory nerve impairments due to direct invasion of LM lesions into nerve canals persisted. Administration of bevacizumab subsequent to whole-brain radiotherapy reduced the cranial nerve impairment, and the patient survived for 10 months. In conclusion, a combination of erlotinib and ventriculoperitoneal shunt was effective for hydrocephalus, and the immediate administration of additional therapies, including bevacizumab and radiation therapy, was useful in a patient suffering from LM. Keywords: bevacizumab, erlotinib, ventriculoperitoneal shunt, leptomeningeal metastases, lung cancer, EGFR" @default.
• W2310361040 created "2016-06-24" @default.
• W2310361040 creator A5001048763 @default.
• W2310361040 creator A5001706604 @default.
• W2310361040 creator A5002407044 @default.
• W2310361040 creator A5007888883 @default.
• W2310361040 creator A5039723911 @default.
• W2310361040 creator A5052603309 @default.
• W2310361040 creator A5056975051 @default.
• W2310361040 creator A5059538840 @default.
• W2310361040 creator A5062920555 @default.
• W2310361040 creator A5066700160 @default.
• W2310361040 date "2016-03-01" @default.
• W2310361040 modified "2023-09-25" @default.
• W2310361040 title "Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation" @default.
• W2310361040 cites W1984841223 @default.
• W2310361040 cites W1991876524 @default.
• W2310361040 cites W1996944145 @default.
• W2310361040 cites W2005674933 @default.
• W2310361040 cites W2007509569 @default.
• W2310361040 cites W2013180980 @default.
• W2310361040 cites W2024572725 @default.
• W2310361040 cites W2025652939 @default.
• W2310361040 cites W2025954997 @default.
• W2310361040 cites W2036782547 @default.
• W2310361040 cites W2057961038 @default.
• W2310361040 cites W2065073049 @default.
• W2310361040 cites W2069496194 @default.
• W2310361040 cites W2073168361 @default.
• W2310361040 cites W2081283472 @default.
• W2310361040 cites W2082148749 @default.
• W2310361040 cites W2088566186 @default.
• W2310361040 cites W2126767708 @default.
• W2310361040 cites W2132416992 @default.
• W2310361040 cites W2136371443 @default.
• W2310361040 cites W2136601558 @default.
• W2310361040 cites W2136963436 @default.
• W2310361040 cites W2156330848 @default.
• W2310361040 cites W2185491429 @default.
• W2310361040 cites W4298981642 @default.
• W2310361040 doi "https://doi.org/10.2147/ott.s95721" @default.
• W2310361040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4809332" @default.
• W2310361040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27042125" @default.
• W2310361040 hasPublicationYear "2016" @default.
• W2310361040 type Work @default.
• W2310361040 sameAs 2310361040 @default.
• W2310361040 citedByCount "4" @default.
• W2310361040 countsByYear W23103610402018 @default.
• W2310361040 countsByYear W23103610402019 @default.
• W2310361040 countsByYear W23103610402021 @default.
• W2310361040 crossrefType "journal-article" @default.
• W2310361040 hasAuthorship W2310361040A5001048763 @default.
• W2310361040 hasAuthorship W2310361040A5001706604 @default.
• W2310361040 hasAuthorship W2310361040A5002407044 @default.
• W2310361040 hasAuthorship W2310361040A5007888883 @default.
• W2310361040 hasAuthorship W2310361040A5039723911 @default.
• W2310361040 hasAuthorship W2310361040A5052603309 @default.
• W2310361040 hasAuthorship W2310361040A5056975051 @default.
• W2310361040 hasAuthorship W2310361040A5059538840 @default.
• W2310361040 hasAuthorship W2310361040A5062920555 @default.
• W2310361040 hasAuthorship W2310361040A5066700160 @default.
• W2310361040 hasBestOaLocation W23103610401 @default.
• W2310361040 hasConcept C104317684 @default.
• W2310361040 hasConcept C121608353 @default.
• W2310361040 hasConcept C126322002 @default.
• W2310361040 hasConcept C143998085 @default.
• W2310361040 hasConcept C185592680 @default.
• W2310361040 hasConcept C2776256026 @default.
• W2310361040 hasConcept C2776694085 @default.
• W2310361040 hasConcept C2777240266 @default.
• W2310361040 hasConcept C2777506169 @default.
• W2310361040 hasConcept C2778087573 @default.
• W2310361040 hasConcept C2778164965 @default.
• W2310361040 hasConcept C2778239845 @default.
• W2310361040 hasConcept C2779013556 @default.
• W2310361040 hasConcept C2779438470 @default.
• W2310361040 hasConcept C2780580887 @default.
• W2310361040 hasConcept C2781182431 @default.
• W2310361040 hasConcept C36823959 @default.
• W2310361040 hasConcept C55493867 @default.
• W2310361040 hasConcept C71924100 @default.
• W2310361040 hasConceptScore W2310361040C104317684 @default.
• W2310361040 hasConceptScore W2310361040C121608353 @default.
• W2310361040 hasConceptScore W2310361040C126322002 @default.
• W2310361040 hasConceptScore W2310361040C143998085 @default.
• W2310361040 hasConceptScore W2310361040C185592680 @default.
• W2310361040 hasConceptScore W2310361040C2776256026 @default.
• W2310361040 hasConceptScore W2310361040C2776694085 @default.
• W2310361040 hasConceptScore W2310361040C2777240266 @default.
• W2310361040 hasConceptScore W2310361040C2777506169 @default.
• W2310361040 hasConceptScore W2310361040C2778087573 @default.
• W2310361040 hasConceptScore W2310361040C2778164965 @default.
• W2310361040 hasConceptScore W2310361040C2778239845 @default.
• W2310361040 hasConceptScore W2310361040C2779013556 @default.
• W2310361040 hasConceptScore W2310361040C2779438470 @default.
• W2310361040 hasConceptScore W2310361040C2780580887 @default.
• W2310361040 hasConceptScore W2310361040C2781182431 @default.
• W2310361040 hasConceptScore W2310361040C36823959 @default.

• next